Polycomb group protein expression during differentiation of human embryonic stem cells into pancreatic lineage in vitro
© Pethe et al.; licensee BioMed Central Ltd. 2014
Received: 24 September 2013
Accepted: 20 May 2014
Published: 24 May 2014
Polycomb Group (PcG) proteins are chromatin modifiers involved in early embryonic development as well as in proliferation of adult stem cells and cancer cells. PcG proteins form large repressive complexes termed Polycomb Repressive Complexes (PRCs) of which PRC1 and PRC2 are well studied. Differentiation of human Embryonic Stem (hES) cells into insulin producing cells has been achieved to limited extent, but several aspects of differentiation remain unexplored. The PcG protein dynamics in human embryonic stem (hES) cells during differentiation into pancreatic lineage has not yet been reported. In the present study, the expression of RING1A, RING1B, BMI1, CBX2, SUZ12, EZH2, EED and JARID2 during differentiation of hES cells towards pancreatic lineage was examined.
In-house derived hES cell line KIND1 was used to study expression of PcG protein upon spontaneous and directed differentiation towards pancreatic lineage. qRT-PCR analysis showed expression of gene transcripts for various lineages in spontaneously differentiated KIND1 cells, but no differentiation into pancreatic lineage was observed. Directed differentiation induced KIND1 cells grown under feeder-free conditions to transition from definitive endoderm (Day 4), primitive gut tube stage (Day 8) and pancreatic progenitors (Day 12-Day 16) as evident from expression of SOX17, PDX1 and SOX9 by qRT-PCR and Western blotting. In spontaneously differentiating KIND1 cells, RING1A and SUZ12 were upregulated at day 15, while other PcG transcripts were downregulated. qRT-PCR analysis showed transcripts of RING1B, BMI1, SUZ12, EZH2 and EED were upregulated, while RING1A and CBX2 expression remained low and JARID2 was downregulated during directed differentiation of KIND1 cells. Upregulation of BMI1, EZH2 and SUZ12 during differentiation into pancreatic lineage was also confirmed by Western blotting. Histone modifications such as H3K27 trimethylation and monoubiquitinylation of H2AK119 increased during differentiation into pancreatic lineage as seen by Western blotting.
Our study shows expression of PcG proteins was distinct during spontaneous and directed differentiation. Differentiation into pancreatic lineage was achieved by directed differentiation approach and was associated with increased expression of PcG proteins RING1B, BMI1, EZH2 and SUZ12 accompanied by increase in monoubiquitinylation of H2AK119 and trimethylation of H3K27.
KeywordshES cells PcG proteins Differentiation Definitive endoderm Pancreatic progenitors
Differentiation of hES cells requires precise orchestration of modifications at chromatin levels, mitochondrial level and changes in cell architecture. Chromatin remodeling is an essential step towards differentiation in the case of pluripotent hES cells [1, 2]. Embryonic stem cells have open chromatin structure which enables them to differentiate into any lineage [3, 4]. Two most widely studied chromatin modifications in ES cells are (i) DNA methylation catalyzed by enzymes like DNMT3a, DNMT3b, DNMT1  and (ii) histone modifications [6, 7] carried out by Polycomb group (PcG) proteins and Trithorax group proteins (TxG). The histone modifications by PcG proteins prevent precocious differentiation of ES cells . PcG proteins may play an important role in the early development, while DNA methylation is involved in gene silencing in differentiated cells .
PcG proteins modify histones by methylation (mono, di, tri methylation) and ubiquitinylation, to bring about repression of genes [9–12]. PcG form multiprotein complexes called Polycomb Repressive Complexes (PRC) such as PRC1 and PRC2 [8, 13, 14]. The PRC1 complex comprises of CBX, BMI1, RING1A, RING1B, PHC, which catalyze monoubiquitinylation of lysine 119 on histone H2A(H2AK119ub1) [15, 16]. Loss of PRC1 protein RING1B is embryo lethal, knockout animals for other PRC1 protein are not embryonically lethal but have several developmental defects [17–19]. The core PRC2 comprises of SUZ12, EED and EZH2 which catalyze the addition of di-methyl or tri-methyl groups to lysine 27 on histone H3 (H3K27me3). PRC2 is essential for embryonic development as evident from knockout mice studies, which show that loss of PRC2 proteins like SUZ12, EZH2 and EED results in embryonic lethality [20–23].
Apart from their requirement for overall development, PcG proteins are involved in proliferation and development of specific cell types like skeletal muscles, neural stem cells, hematopoietic cells [20, 24–26]. PcG proteins such as BMI1 and EZH2 are often found to be overexpressed in cancer cells [27–29].
Hence, it becomes important to study the dynamics of polycomb group proteins during development of various cell types in humans. The best model to study the PcG expression during early development in humans is differentiating embryonic stem cells. hES cells are pluripotent cells with potential to differentiate into all three lineages viz. endoderm, mesoderm and ectoderm [30, 31]. Previous reports have studied PcG proteins in ES cells differentiating into ectoderm and mesoderm [9, 32, 33]. Recently polycomb mediated histone modifications (H3K27me3 and H3K4me3) at key genes during differentiation of hES cells into pancreatic lineage was reported . One of the important area of research has been differentiation of hES cells into functional islet cells for treatment of type I diabetes [26, 35–37]. Even though PcG proteins are crucial during differentiation, there are no reports available as yet of dynamics of PcG expression during differentiation into pancreatic lineage.
In the present study, in-house derived hES cell line KIND1 [30, 38] was differentiated into pancreatic lineage under feeder-free culture system by two strategies viz spontaneous and directed differentiation. The expression of PcG protein transcript RING1A, RING1B, BMI1, CBX2, SUZ12, EZH2, EED and JARID2 was examined during differentiation of KIND1 and compared to the pattern in adult human pancreatic RNA.
Differentiation of KIND1 hES cells
Feeder-free culture of KIND1 cells
Differentiation of feeder-free KIND1 cells into pancreatic lineage
Polycomb group protein dynamics during differentiation
We first examined the expression of PcG expression in KIND1 cultured on HFF and under feeder free system, followed by studying PcG expression in differentiated KIND1 cells.
KIND1 cultured on human feeder fibroblasts
Feeder-free KIND1 cells
The expression of PRC1 gene transcripts showed similar expression pattern to that seen when KIND1 cells were cultured on HFF. RING1B was significantly expressed more compared to BMI1, RING1A, CBX2 while among the PRC2 SUZ12 was expressed significantly more than EZH2, JARID2 and EED (Figure 4C and D).
Expression of p19/ARF
Polycomb group protein expression in adult human pancreatic RNA
Of the PRC1 proteins, BMI1 is expressed higher than RING1A, RING1B and CBX2 (Figure 9A), while among PRC2 complex, EED and SUZ12 is expressed to higher amounts while expression to EZH2 and JARID 2 transcripts is low (Figure 9B).
PRC2 group proteins have been shown to be dispensable for pluripotency; however they are required during differentiation shown by both in vivo and in vitro studies [32, 39]. Though importance of PcG proteins during differentiation is known, their expression during differentiation of hES cells into pancreatic lineage has not yet been evaluated. To achieve this, we differentiated KIND1 via spontaneous differentiation and directed differentiation. EBs showed higher expression of endoderm and mesoderm gene transcript while lower expression of ectoderm gene transcripts was seen. However gene transcripts for PDX1, SOX9 and NKX6.1 were not detected in differentiated EBs. Hence, KIND1 cells were differentiated by directed differentiation which involves sequential addition of cytokines to generate cells of pancreatic lineage, and this necessitated culturing KIND1 cells under feeder free conditions. The PcG gene transcripts profile of feeder-free KIND1 cells was similar to KIND1 cells cultured on HFF cells.
Upregulation of pluripotency controlling gene NANOG on day 4 indicated that it may be required for endoderm differentiation, in contrast to its role in maintaining undifferentiated state. Previous reports have also shown that these transcription factors are involved in lineage specification and differentiation [40–42]. Gene transcripts of ectodermal marker (MAP2), cardiac mesoderm marker (MESP1) were seen at low level during pancreatic differentiation, indicating differentiation of KIND1 cells primarily into endoderm lineage. Pancreas specific gene transcripts PDX1, SOX9 and NKX6.1 were expressed during later stages of differentiation (day12-day16) which was also confirmed by Western blotting, indicating the differentiation of KIND1 cells into cells of pancreatic lineage by directed differentiation.
Once the differentiation of KIND1 into pancreatic lineage was achieved, we studied the expression of PcG proteins. BMI1 has been shown to be important for self renewal and differentiation of neural stem cells and hematopoietic stem cells. BMI1 represses the expression of cell cycle inhibitors like p21, p19 and p16, leading to proliferation of stem cells [25, 26, 43, 44]. BMI1 was found to be highly expressed during directed differentiation of KIND1 cells into pancreatic lineage and this is being reported for the first time. We found the increased expression of BMI1 led to decrease in expression of p19/CDKN2D transcript. CBX2 and RING1A gene transcript levels remain almost unaltered during differentiation, thus it suggests that CBX2 and RING1A may not play important role during endoderm differentiation. RING1B transcript was significantly upregulated during differentiation compared to undifferentiated KIND1 cells. We found the increased RING1B and BMI1 led to increase in H2AK119ub1 levels during differentiation. Total adult human pancreatic RNA also showed higher expression of BMI1 than RING1A, RING1B and CBX2 thus highlighting role of BMI1 in differentiated endodermal cells.
In mice EZH2, SUZ12, EED and JARID2 knockout results in embryonic lethality [11, 22, 45, 46]. Our data shows that EZH2, EED and SUZ12 transcript expression increased compared to undifferentiated KIND1 cells during differentiation. On the other hand, JARID 2 levels decreased steadily during both directed and spontaneous differentiation, similar to results obtained by earlier groups [7, 34]. Studies carried out earlier have shown EZH2, EED decrease upon differentiation of mouse ES cells [6, 47, 48]. Also, previous reports that studied expression of PcG proteins in differentiated embryonic stem cells, have used spontaneous differentiation approach to induce differentiation [8, 9, 48, 49]. Van Arensbergen et al.  reported that pancreatic progenitors have high levels of H3K27me3 which gives them plasticity to differentiate either to acinar or beta cell. PRC2 proteins EED, SUZ12 and EZH2 are actively involved in H3K27me3 modification [6, 7]. Results of the present study show that SUZ12, EZH2 and EED were upregulated during differentiation of KIND1 cells into pancreatic cells along with an increase in the H3K27me3 levels. The expression profile of PRC2 proteins at the transcript level observed in adult human pancreas is similar to that seen in KIND1 cells differentiated into pancreatic lineage.
The expression of RING1B, BMI1, EZH2, EED, and SUZ12 gene transcripts during spontaneous and directed differentiated hES cells indicates that changes in PcG expression is not a generalized phenomenon observed during differentiation. The increase in expression of PcG proteins correlated with increase in trimethylation of histone H3K27 and monoubiquitinylation at H2AK119. Understanding the dynamics of polycomb group proteins during hES cell differentiation may help to design better differentiation strategies in future.
We show that directed differentiation resulted in generation of cells of pancreatic lineage. Our data shows that expression of PRC1 and PRC2 members had distinct expression profile depending on whether KIND1 cells were subjected to directed or spontaneous differentiation. Expression of PRC1 transcripts RING1B and BMI1; PRC2 transcripts SUZ12, EZH2 and EED, increased during pancreatic differentiation, which resulted in increase in H2AK119ub1 and H3K27me3 modification. PRC1 group protein RING1B and BMI1 and PRC2 group protein EZH2 and SUZ12 are expressed during differentiation into pancreatic lineage. This study will initiate more research on PcG proteins and their role in cell differentiation.
Human ES cells culture on HFF
All chemicals for cell culture were obtained from Invitrogen (Carlsbad, CA, USA), unless otherwise indicated. The culture and passaging was done as described earlier . KIND1 colonies were passaged manually in 1:3 ratio once every week.
Adapting KIND1 cells to feeder-free culture conditions
KIND1 cells were adapted to grow on Geltrex by gradually reducing the HFF density while maintaining recommended concentration of Geltrex. For feeder-free culture, KIND1 cells were grown on 60 mm dish coated with Geltrex as per manufacturer’s instructions in StemPro hESC SFM media supplemented with 10 ng/mL of bFGF (R & D Systems, MN, USA) at 37°C in a humidified atmosphere with 5% CO2. Passaging was done mechanically using Cell Lifter (Sigma Aldrich, MO, USA) in 1:3 ratio.
RT-PCR for evaluating expression of pluripotent markers
Total RNA was extracted using TRIzol reagent (Invitrogen) as per manufacturer’s instructions. DNase I (Invitrogen) treatment was done at 37°C for 30 minutes and spectrophotometric quantification of the extracted RNA was done using Ultrospec 3100 pro (GE Healthcare, PA, USA). The cDNA was synthesized using iScript cDNA Synthesis Kit (Bio-Rad Laboratories, CA, USA) in a 20 μL reaction volume according to the manufacturer’s instructions using GSTORM thermal cycler (Gene Technologies, Braintree, UK). For all the genes, the cycling parameters for PCR comprised of initial denaturation at 94°C for 3 min, followed by 35 cycles of denaturation at 94°C for 30 sec, primer annealing at 62°C for 30 sec and extension at 72°C for 1 min using Dream Taq Polymerase as per manufacturer’s instructions (Thermo Scientific, IL, USA). The primers used for RT-PCR are as described earlier . The PCR products were visualized by electrophoresis on 2% agarose gel, containing 0.5 μg/ml ethidium bromide (Bangalore Genei, Bangalore, India) and the product size was approximated using 100-bp DNA ladder (Bangalore Genei).
Karyotyping of feeder-free hES cells
KIND1 colonies were treated with 0.2 μg/mL colchicine (Sigma Aldrich) for 3 hrs and harvested using 1× accutase (Invitrogen) followed by treatment with hypotonic solution of 0.075 M KCl (Sigma Aldrich) for 20 min at 37°C. After treatment, cells were pelleted by centrifugation and fixed by addition of cold fixative made of methanol and acetic acid in ratio of 3:1(Qualigens Fine Chemicals, Mumbai, India),followed by G-banding for metaphase analysis. More than 20 metaphases were analyzed to prepare the karyogram.
Differentiation of KIND1 hES cells
Spontaneous differentiation by embryoid body (EB) formation
Embryoid bodies were prepared and cultured as described earlier  and EBs were harvested at Day 7 and Day 15. For plating, the EBs (7 days post suspension culture) were plated on gelatin coated dishes for 10 days in same media as used for EBs in suspension culture and later harvested for RNA extraction.
Directed differentiation of feeder free KIND1 cells into pancreatic lineage
The protocol published earlier by Kroon et al.  was used to differentiate hES cells into pancreatic endoderm with slight modifications. KIND1 feeder free cells showing 80% confluency were cultured using RPMI 1640 media containing 100 ng/mL activin A (R & D Systems), 1 mM sodium butyrate (Sigma Aldrich), and 25 ng/mL wnt-3a (R & D Systems). After 24 hours, 0.2% fetal bovine serum (FBS) was added to RPMI media along with 100 ng/mL activin A, 0.5 mM sodium butyrate. On days 3 & 4 the RPMI media was supplemented with 2% FBS and 100 ng/mL activin A. From day 4 onwards, the basal medium used was DMEM F12 supplemented with 1× B27, 2 μM retinoic acid (Sigma Aldrich), 50 ng/mL noggin (R & D Systems), 0.25 μM cyclopamine (Sigma Aldrich) for 4 days. During the last stage of differentiation, the differentiating cells were cultured in DMEM along with 1× B27 supplement, 2 μM retinoic acid, 50 ng/mL noggin, 1 mM nicotinamide (Sigma Aldrich), 1× non-essential amino acids and 25 μg/mL FGF-10 (R & D Systems).
qRT-PCR analysis to monitor differentiation of hES cells and PcG expression pattern
List of all the primer sequences used for qRT-PCR analysis
Primer sequence 5′- 3′
R - CCTCCAATGGATCCTCGTTA
F - ACGATGCCCAGCAGCAATGACT
F - GTGCCCTTCAGCCAGACTATAACC
R - TGCGCGGCTCCAGGAAAATG
F - GGCAGCAGGTAGCAAAGTGACGC
R - AGAGGAGGTCGGCCACTGACA
F – TGCCATTGTGTGCTGGAAACCTGG
R - GCCCAATGCAAGCATCTTTTGCC
F - TTCTGGCTTCCGTGCCCACG
R - CATGCGCCTGCCCTGTTTCGTA
F - AGGAGGAAAACGGGAAAGAA
R - CAACAACAGCAATGGAGGAG
F - CCCAGCCCCCTAAGAGAGCAC
R - CCCAGCCCCCTAAGAGAGCAC
F – TGCACAAGCCGCAGGACTCG
R - ACAGCCCCCTATGAGCGGGAG
R - CCAATTGAACCCATGTAAAGCC
F - AGTCCAGGATCCAGGTATGGTTCC
F - AACTGGGCCAGGAGCTGACCA
F - AGTCCCAAAGGCAAACAACCCACTTC
F - AGCCCTCATTTCACCAGGCC
F - AAGGGCGAGTCCCGTATC
The expression of gene transcripts specific for definitive endoderm (Day 4), pancreatic gut tube (Day 8), pancreatic progenitor (Days12-16), PRC1 and PRC2 gene transcripts in differentiated cells is expressed relative to undifferentiated KIND1 cells (set as 1).
For expression of PcG gene transcripts in adult human pancreatic RNA (Clonetech Laboratories Inc., CA, USA) and KIND1 cells (cultured on HFF and on feeder free system) the PcG gene transcript, Cts were normalized using housekeeping gene 18S Cts, expression shown is relative to highest detectable (Ct 40). Mean ∆Ct values from qRT-PCR analyses were compared using the unpaired, two-tailed Student’s t-test, p values <0.05 were considered significant, error bars in graphs represent ± Standard Error of Mean. The Co-efficient of variance was found to be ≤ 27%.
Western blotting to assess pluripotency, differentiation and PcG expression
Undifferentiated and differentiated KIND1 feeder free cells were harvested for protein extraction using ice cold cell lysis buffer containing 50 mM Tris (SRL, Mumbai, India), 1 mM EDTA (Fischer Scientific, NY, USA),150 mM NaCl (Sigma Aldrich), 1 M NaF (Fischer Scientific), 0.1% SDS (Fischer Scientific), 1% triton X-100 (Sigma Aldrich), 2 mM PMSF (Sigma Aldrich) and containing Protease Inhibitor Cocktail (Roche Diagnostics GmbH, Manheim, Germany). The cell lysate was agitated on ice for 30 minutes followed by centrifugation to collect the supernatant. For extraction of histone proteins protocol followed was as described by de Napoles et al. 2004 . Protein concentration was estimated by Folin-Lowry method using spectrophotometer (Beckman Coulter Inc, IN, USA). The extracted protein was incubated in Laemmli buffer for 10 minutes at 95°C. 10–20 μg of protein was loaded onto 10% or 15% SDS-PAGE followed by transfer onto PVDF membrane (Amersham Biosciences, Bucks, UK). The blot was blocked with 5% NFDM in 1XTBST overnight at 4°C. Primary antibody mouse anti OCT-4 (1:500, Millipore, CA, USA), rabbit anti SOX17 (1:2000, Millipore), rabbit anti SOX9 (1:500, Millipore), mouse anti PDX1 (1:20000, Sigma Aldrich), rabbit anti EZH2 (1:2500, Epitomics, California, USA), rabbit anti SUZ12 (1:2000, Millipore), rabbit anti BMI1(1:3000, Epitomics), mouse anti H3K27me3 (1:5000, Abcam, MA, USA), Mouse Anti H2AK119ub1 (1:2000, Millipore) were incubated at RT for 2 hours followed by incubation with goat anti mouse/rabbit HRP conjugated secondary antibody (1:5000, Millipore) for 2 hours at RT. Later blot was striped using stripping buffer (62.5 mM Tris, 2% SDS,100 mM β-mercaptoethanol) for 10 minutes at 60°C. Mouse anti β ACTIN (1:5000, Millipore) and rabbit anti-Histone H3 (1:3000, Biolegend, CA, USA) were used as housekeeping protein for normalization. The blots were imaged using Super Signal West Femto substrate (Thermo Scientific) and photographic films (Eastman Kodak Co, USA). Densitometric analysis was done using ImageJ software (http://rsbweb.nih.gov/ij/).
The project (BT/PR11747/MED/31/63/2008) was partly funded by Department of Biotechnology (DBT), Govt of India. We also acknowledge University Grants Commission (UGC), Govt of India for providing fellowship to PP.
- Delgado-Olguin P, Recillas-Targa F: Chromatin structure of pluripotent stem cells and induced pluripotent stem cells. Brief Funct Genomics. 2011, 10: 37-49. 10.1093/bfgp/elq038.PubMed CentralView ArticlePubMedGoogle Scholar
- Paige SL, Thomas S, Stoick-Cooper CL, Wang H, Maves L, Sandstrom R, Pabon L, Reinecke H, Pratt G, Keller G, Moon RT, Stamatoyannopoulos J, Murry CE: A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell. 2012, 151 (1): 221-232. 10.1016/j.cell.2012.08.027.PubMed CentralView ArticlePubMedGoogle Scholar
- Gaspar-Maria A, Alajem A, Polesso E, Sridharan R, Mason MJ, Heiderbach A, Ramalho-Santos J, McManus MT, Plath K, Meshorer E, Ramalho-Santos M: Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature. 2009, 460: 863-868.Google Scholar
- Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, Edsall LE, Kuan S, Luu Y, Klugman S, Antosiewicz-Bourget J, Ye Z, Espinoza C, Agarwahl S, Shen L, Ruotti V, Wang W, Stewart R, Thomson JA, Ecker JR, Ren B: Distinct epigenomic landscapes of pluripotent and lineage committed human cells. Cell Stem Cell. 2010, 6 (5): 479-491. 10.1016/j.stem.2010.03.018.PubMed CentralView ArticlePubMedGoogle Scholar
- Fisher CL, Fisher AG: Chromatin states in pluripotent differentiated and reprogrammed cells. Curr Opin Genet Dev. 2011, 21: 140-146. 10.1016/j.gde.2011.01.015.View ArticlePubMedGoogle Scholar
- Kuzmichev A, Margueron R, Vaquero A, Preissner TS, Scher M, Kirmizis A, Iuoyang X, Brockdorff N, Abate-Shen C, Farnham P, Reinberg D: Composition and histone substrates of polycomb repressive complexes change during cellular differentiation. Proc Natl Acad Sci U S A. 2005, 102: 1859-1864. 10.1073/pnas.0409875102.PubMed CentralView ArticlePubMedGoogle Scholar
- Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O’Donovan A, Presser A, Russ C, Xie X, Meissner A, Werni M, Jaenisch R, Nusbaum C, Lander ES, Berstein BE: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007, 448: 553-560. 10.1038/nature06008.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K, Murray H, Zucker JP, Yuan B, Bell GW, Herbolsheimerm E, Hannett NM, Sun K, Odum D, Qtte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, Young RA: Control of developmental regulators by polycomb in human embryonic stem cells. Cell. 2006, 125: 301-313. 10.1016/j.cell.2006.02.043.PubMed CentralView ArticlePubMedGoogle Scholar
- Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros L, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, Gifford DK, Young RA, Jaenisch R: Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006, 441: 349-353. 10.1038/nature04733.View ArticlePubMedGoogle Scholar
- Dietrich N, Lerdrup M, Landt E, Agarwal-Singh S, Bak M, Tommerup N, Rappsilber J, Sodersten E, Hansen K: REST-mediated recruitment of polycomb repressor complexes in Mammalian cells. PLoS Genet. 2012, 8 (3): e1002494-10.1371/journal.pgen.1002494.PubMed CentralView ArticlePubMedGoogle Scholar
- Pietersen AM, Van Lohuizen M: Stem cell regulation of polycomb repressors: postponing commitment. Curr Opin Cell Biol. 2008, 20: 201-207. 10.1016/j.ceb.2008.01.004.View ArticlePubMedGoogle Scholar
- Richly A, Aloia L, Di Croce L: Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis. 2011, 2: e204-10.1038/cddis.2011.84. doi:10.1038/cddis.2011.84PubMed CentralView ArticlePubMedGoogle Scholar
- Morey L, Pasual G, Cozzuto L, Roma G, Wutz A, Benitah SA, DiCroce L: Nonoverlapping functions of the polycomb group group cbx family of proteins in embryonic stem cells. Cell Stem Cell. 2012, 10: 47-62. 10.1016/j.stem.2011.12.006.View ArticlePubMedGoogle Scholar
- Rajasekhar VR, Begemann M: Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells. 2007, 25: 2498-2510. 10.1634/stemcells.2006-0608.View ArticlePubMedGoogle Scholar
- Cao R, Tsukada Y, Zhang Y: Role of Bmi-1 and Ring1A in H2A Ubiquitylation and Hox Gene Silencing. Mol Cell. 2005, 20: 845-854. 10.1016/j.molcel.2005.12.002.View ArticlePubMedGoogle Scholar
- de Napoles M, Mermoud JE, Wakao R, Tang YA, Appanah R, Nesterova TB, Silva J, Otte AP, Vidal M, Koseki H, Brockdorff N: Polycomb Group Proteins Ring1A/B Link Ubiquitylation of Histone H2A to Heritable Gene Silencing and X Inactivation. Dev Cell. 2004, 7: 663-676. 10.1016/j.devcel.2004.10.005.View ArticlePubMedGoogle Scholar
- Akasaka T, van Lohuizen M, van der Lugt N, Mizutani-Koseki Y, Kanno M, Taniguchi M, Vidal M, Alkema M, Berns A, Koseki H: Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development. 2001, 128: 1587-1597.PubMedGoogle Scholar
- del Mar LM, Marcos-Gutiérrez C, Pérez C, Schoorlemmer J, Ramírez A, Magin T, Vidal M: Loss- and gain-of-function mutations show a Polycomb group function for Ring1A in mice. Development. 2000, 127: 5093-5100.Google Scholar
- Voncken JW, Roelen BJ, Roefs M, de Vries S, Verhoeven E, Marino S, Deschamps J, van Lohuizen M: Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. Proc Natl Acad Sci U S A. 2003, 100: 2468-2473. 10.1073/pnas.0434312100.PubMed CentralView ArticlePubMedGoogle Scholar
- Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su I, Hannon G, Tarakhovsky A, Fuchs E: Ezh2 orchestrates gene expression for the stepwise differentiation of tissue–specific. Stem Cells. 2009, 136 (6): 122-1135.Google Scholar
- Landeira D, Fisher AG: Inactive yet indispensable: the tale of Jarid2. Trends Cell Biol. 2011, 21: 74-80. 10.1016/j.tcb.2010.10.004.PubMed CentralView ArticlePubMedGoogle Scholar
- Pasini D, Bracken AP, Jensen MR, Denchi EL, Helin K: Suz12 is essential for mouse development and for EZH2 histone methyltranferase activity. EMBO J. 2004, 23: 4061-4071. 10.1038/sj.emboj.7600402.PubMed CentralView ArticlePubMedGoogle Scholar
- Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR, Yuan GC, Lee Y, Orkin SH: Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell. 2009, 139: 1303-1314. 10.1016/j.cell.2009.12.003.PubMed CentralView ArticlePubMedGoogle Scholar
- Caretti G, Padova M, Micales B, Lyons GE, Sartorelli V: The Polycomb Ezh2 methyltranferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev. 2004, 18: 2627-2638. 10.1101/gad.1241904.PubMed CentralView ArticlePubMedGoogle Scholar
- Fasano CA, Phoenix TN, Kokovay E, Lowry N, Elkabetz Y, Dimos JT, Lemischk IR, Studer L, Temple S: Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev. 2009, 23: 561-571. 10.1101/gad.1743709.PubMed CentralView ArticlePubMedGoogle Scholar
- Molofsky A, Pardal R, Iwashita T, Park I, Clarke MF, Morrison S: Bmi-1 dependence distinguishes neural stem cells self–renewal from progenitor proliferation. Nature. 2003, 425: 962-967. 10.1038/nature02060.PubMed CentralView ArticlePubMedGoogle Scholar
- Bryant RJ, Cross NA, Eaton CL, Hamdy FC, Cunliffe VT: EZH2 promotes proliferation and invasiveness of prostate cancer cells. Prostate. 2007, 67: 547-556. 10.1002/pros.20550.View ArticlePubMedGoogle Scholar
- Sasaki M, Yamaguchi J, Ikeda H, Itatsu K, Nakanuma Y: Polycomb group protein Bmi1 is overexpressed and essential in anchorage-independent colony formation, cell proliferation and repression of cellular senescence in cholangiocarcinoma Tissue and culture studies. Hum Pathol. 2009, 40: 1723-1730. 10.1016/j.humpath.2009.01.027.View ArticlePubMedGoogle Scholar
- Weikert S, Christoph F, Köllermann J, Müller M, Schrader M, Miller K, Krause H: Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med. 2005, 16 (2): 349-353.PubMedGoogle Scholar
- Kumar N, Hinduja I, Nagvenkar P, Pillai L, Zaveri K, Mukadam L, Telang J, Desai S, Mangoli V, Mangoli R, Padgaonkar S, Kaur G, Puri C, Bhartiya D: Derivation and characterization of two genetically unique human embryonic stem cell Lines on in-house- derived human feeders. Stem Cells Dev. 2009, 18: 67-77. 10.1089/scd.2008.0002.View ArticleGoogle Scholar
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science. 1998, 282: 1145-1147.View ArticlePubMedGoogle Scholar
- Pasini D, Bracken AP, Hansen JB, Manuela C, Helin K: The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol. 2007, 10: 3769-3779.View ArticleGoogle Scholar
- Woo CJ, Kharchenko PV, Daheron L, Park PJ, Kingston RE: A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell. 2010, 140 (1): 99-110. 10.1016/j.cell.2009.12.022.PubMed CentralView ArticlePubMedGoogle Scholar
- Xie R, Everett LJ, Lim HW, Patel NA, Schug J, Kroon E, Kelly OG, Wang A, D’Amour KA, Robins AJ, Won KJ, Kaestner KH, Sander M: Dynamic chromatin remodeling mediated by Polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. Cell Stem Cell. 2013, 12 (2): 224-237. 10.1016/j.stem.2012.11.023.PubMed CentralView ArticlePubMedGoogle Scholar
- Dominguez-Bendalaa J, Inverardia L, Ricordi C: Stem cell-derived islet cells for transplantation. Curr Opin Organ Transplant. 2011, 16: 76-82. 10.1097/MOT.0b013e32834252b5.View ArticleGoogle Scholar
- Hoof DV, D’Amour KA, German M: Derivation of insulin-producing cells from human embryonic stem cells. Stem Cell Res. 2009, 3: 73-87. 10.1016/j.scr.2009.08.003.View ArticlePubMedGoogle Scholar
- Mfopou JK, Chen B, Sui L, Sermon K, Bouwens L: Recent advances and prospects in the differentiation of pancreatic cells from human embryonic stem cells. Diabetes. 2010, 59: 2094-2101. 10.2337/db10-0439.PubMed CentralView ArticlePubMedGoogle Scholar
- Nagvenkar P, Pethe P, Pawani H, Telang J, Kumar N, Hinduja I, Zaveri K, Bhartiya D: Evaluating differentiation propensity of in-house derived human embryonic stem cell lines KIND-1 and KIND-2. In Vitro Cell Dev Biol Anim. 2011, 47: 406-419. 10.1007/s11626-011-9420-9.View ArticlePubMedGoogle Scholar
- Stojic L, Jasencakova Z, Prezioso C, Stützer A, Bodega B, Pasini D, Klingberg R, Mozzetta C, Margueron R, Puri PL, Schwarzer D, Helin K, Fischle W, Orlando V: Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells. Epigenetics Chromatin. 2011, 4: 16-10.1186/1756-8935-4-16.PubMed CentralView ArticlePubMedGoogle Scholar
- Kopp JL, Ormsbee BD, Desler M, Rizzino A: Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells. 2008, 26 (4): 903-911. 10.1634/stemcells.2007-0951.View ArticlePubMedGoogle Scholar
- Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000, 24: 372-376. 10.1038/74199.View ArticlePubMedGoogle Scholar
- Teo AK, Arnold SJ, Trotter MW, Brown S, Ang LT, Chng Z, Robertson EJ, Dunn NR, Vallier L: Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev. 2011, 25: 238-250. 10.1101/gad.607311.PubMed CentralView ArticlePubMedGoogle Scholar
- Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H, Ema H, Kamijo T, Katoh-Fukui Y, Koseki H, van Lohuizen M, Nakauchi H: Enhanced self renewal of hematopoietic stem cell self renewal mediated by the polycomb gene product Bmi-1. Immunity. 2004, 21: 843-851. 10.1016/j.immuni.2004.11.004.View ArticlePubMedGoogle Scholar
- Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF: Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003, 42 (3): 302-305.View ArticleGoogle Scholar
- Surface LE, Thornton SR, Boyer LA: Polycomb group proteins Set the stage for early lineage commitment. Cell Stem Cell. 2010, 7: 288-298. 10.1016/j.stem.2010.08.004.View ArticlePubMedGoogle Scholar
- Zhang Z, Jones A, Sun CW, Li C, Chang CW, Joo HY, Dai Q, Mysliwiec MR, Wu LC, Guo Y, Yang W, Liu K, Pawlik KM, Erdjument-Bromage H, Tempst P, Lee Y, Min J, Townes TM, Wang H: PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells. 2011, 29 (2): 229-240. 10.1002/stem.578.PubMed CentralView ArticlePubMedGoogle Scholar
- de la Cruz C, Fang J, Plath K, Worringer KA, Nusinow DA, Zhang Y, Panning B: Developmental regulation of Suz12 localization. Chromosoma. 2005, 114 (3): 183-192. 10.1007/s00412-005-0008-6.View ArticlePubMedGoogle Scholar
- Lee ER, Murdoch FE, Fristsch MK: High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid. Stem Cells. 2007, 25: 2191-2199. 10.1634/stemcells.2007-0203.View ArticlePubMedGoogle Scholar
- Qin J, Whyte WA, Anderssen E, Apostolou E, Chen HH, Akbarian S, Bronson RT, Hochedlinger K, Ramaswamy S, Young RA, Hock H: The polycomb group protein L3mbtl2 assembles an atypical PRC1-family complex that is essential in pluripotent stem cells and early development. Cell Stem Cell. 2012, 11 (3): 319-332. 10.1016/j.stem.2012.06.002.PubMed CentralView ArticlePubMedGoogle Scholar
- Van Arensbergen J, García-Hurtado J, Ignasi Moran I, Maestro MA, Xu X, de Casteele MV, Skoudy AL, Palassini M, Heimberg H, Ferrer J: Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Res. 2010, 20 (6): 722-732. 10.1101/gr.101709.109.PubMed CentralView ArticlePubMedGoogle Scholar
- Kroon E, Martinson LA, Kadoya K, Bang AB, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD, D’Amour KA, Carpenter MK, Baetge E: Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008, 26: 443-452. 10.1038/nbt1393.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.